U.S. President Donald Trump, reacting to not winning the Nobel Peace Prize this year, said, "I'm happy because I saved millions of lives," signaling expectations for next year's award.
At a White House event on the 10th (local time), when asked about not being awarded the Nobel Peace Prize, President Trump said, "There are people who say they (the Nobel Committee) should have (chosen President Trump) because we did a lot. You could say (this year's Nobel Peace Prize) was given for what was done in 2024, and I was running in the 2024 election (the presidential election)," he said.
This can be read to mean that this year's Nobel Peace Prize recognized activities done in 2024, but that he, as president, was active in 2025, so he did not receive it this year. Previously, President Trump repeatedly claimed that after taking office he ended eight wars through peace agreements and mediation, including a Gaza Strip cease-fire agreement between Israel and Hamas.
Trump also said that Maria Corina Machado of Venezuela, who was selected as the Nobel Peace Prize laureate, called him and said, "I am receiving the prize in honor of you. You really deserve (this award)." Trump added, "(That was) very kind. I did not say, 'Then give me the prize.' If I had, I think she might have given it. She was very kind," he said.
Meanwhile, that day President Trump announced a drug price reduction agreement with pharmaceutical company AstraZeneca. The main point is that AstraZeneca will supply all prescription drugs to Medicaid (health insurance for low-income people) at most-favored-nation (MFN) prices going forward. The most-favored-nation price Trump refers to means the lowest price among the prices a pharmaceutical company applies to advanced countries outside the United States.
AstraZeneca will also sell all medicines it launches in the U.S. market at discounted prices going forward. It has decided to invest $50 billion in the United States over the next five years, and AstraZeneca will be exempted from drug tariffs for three years.
Earlier, on the 30th of last month, President Trump announced at a briefing held at the White House with Pfizer Chief Executive Officer (CEO) Albert Bourla that Pfizer would sell all new drugs it launches in the U.S. market at most-favored-nation prices.